This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Complix Nv. Active years: 2017-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2018
Title: Innovator Klaartje Somers: Pioneering Patents in Biomedicine
Introduction: Klaartje Somers, based in Kortessem, Belgium, is a distinguished inventor known for her contributions to biomedicine. With a total of two patents to her name, she is making significant strides in the development of innovative polypeptides for various medical applications.
Latest Patents: Klaartje Somers' latest patents showcase her expertise in the field. The first patent involves polypeptides capable of cellular internalization, which can cross cellular membranes to enter the intracellular environment. These polypeptides are valuable for prophylactic, therapeutic, and diagnostic applications, as well as screening and detection methods. Furthermore, her research includes nucleic acids encoding such polypeptides, preparation methods, host cells that express them, and pharmaceutical compositions that incorporate these advancements.
The second patent focuses on polypeptides that specifically bind to IL-23. This includes Alphabodies, which have a high affinity for IL-23 and are critical in the development of targeted therapeutic solutions. Additionally, this patent encompasses nucleic acids encoding these Alphabodies and various methods for their preparation, alongside pharmaceutical compositions that utilize these innovative polypeptides.
Career Highlights: Klaartje Somers is affiliated with Complix NV, a company dedicated to the development of innovative biopharmaceuticals. Her work here has played a pivotal role in advancing the company's mission to improve health outcomes through novel therapeutic solutions.
Collaborations: Throughout her career, Klaartje has collaborated with notable colleagues such as Stefan Loverix and Ignace Lasters. These partnerships highlight the collective efforts in the biopharmaceutical field, furthering research and innovation in the healthcare sector.
Conclusion: Klaartje Somers exemplifies innovation in the realm of biomedicine through her patents and collaborations. With her focus on the development of novel polypeptides, her contributions continue to impact therapeutic strategies and improve patient care. Her journey is a testament to the power of creativity and scientific research in transforming healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile